RENÉE AGUIAR LUCANDER CEO

Roles

Hansa Biopharma AB Stockholm
CEO
24.07.202528.07.2025

Transactions (including via associated entities)

DateIssuerNatureVolumePriceValueSource
28.07.2025Hansa Biopharma AB Stockholm
Bought — open marketAcquisition
50,000SEK 27.40
SEK 1,370,000.00
27.07.2025Hansa Biopharma AB Stockholm
Bought — open marketAcquisition
1,652,500SEK 10.89
SEK 17,995,725.00
24.07.2025Hansa Biopharma AB Stockholm
Bought — open marketAcquisition
100,000SEK 27.00
SEK 2,700,000.00